Author

E. L. Nuermberger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 1

Frequent Co-Authors

S.-Y. Li· 2 shared a. garcia-perez· 1 shared A. Mendoza-Losana· 1 shared B. N. Kreiswirth· 1 shared D. BARROS-AGUIRRE· 1 shared D. Rifat· 1 shared H. Soni· 1 shared I. Sosi?· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

S.-Y. Li

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

In vitro and in vivo validation of cwlM and pbpB essentiality for viability and resistance to imipenem in Mycobacterium abscessus

E. L. Nuermberger, J. I. Lee, S.-Y. Li, D. Rifat, N. Kurepina, L. Chen, B. N. Kreiswirth

This study validates cwlM and pbpB as essential genes for Mycobacterium abscessus viability and imipenem resistance using CRISPRi in vitro and in vivo.

bioRxiv · Mar 8, 2024 · PreprintMicrobiology

Direct inhibitors of InhA with efficacy similar or superior to isoniazid in novel drug regimens for tuberculosis

L. Encinas, S.-Y. Li, J. Rullas-Trincado, R. Tasneen, S. TYAGI, H. Soni, a. garcia-perez, J. Lee, R. Gonzalez del Rio, J. De Mercado, V. Sousa, I. Sosi?, S. Gobec, A. Mendoza-Losana, P. J. Converse, , E. L. Nuermberger

This study evaluates direct inhibitors of InhA (DIIs) for tuberculosis treatment, showing their efficacy comparable to isoniazid and their potential in new drug regimens.

bioRxiv · Mar 8, 2024 · PreprintPharmacology & Toxicology